Overview
Aqdot develops supramolecular chemistry solutions using patented AqFresh™ technology based on cucurbiturils for molecule capture, holding, and controlled release. In pharmaceuticals, it supports encapsulation platforms for controlled release strategies and offers ingredients like Aq™Bit and AqStar™ M1 with Platinum Material Health Certificates for safer chemical applications. The company licenses its technology to manufacturers, enabling innovations in drug delivery, pollutant capture, and sustainable production.
Frequently asked questions
- What pharmaceutical capabilities does Aqdot offer?
- Aqdot provides a novel encapsulation platform using microfluidic droplets and supramolecular host-guest interactions for controlled release in pharmaceuticals, protected by four patents.
- What regulatory certifications do Aqdot products have?
- Aq™Bit and AqStar™ M1 have achieved Platinum level Material Health Certificates from the Cradle to Cradle Products Innovation Institute, confirming no risks to humans or the environment at concentrations of 100 ppm or above.
- What are Aqdot's geographic operations and partnerships?
- Headquartered in Cambridge, England, Aqdot expanded to the U.S. in 2019 and partners globally, including with Clariant for laundry and dishwash applications using AqFresh™ technology.